Curcumin protects trabecular meshwork cells against hydrogen peroxide-induced oxidative stress and apoptosis via Nrf2-keap1 pathway
AbstractPurpose: To explore the effects and molecular mechanism of action of curcumin on trabecular meshwork cells (TMCs).
Methods: TMCs were isolated from pig eyes and NF-E2-related factor 2 (Nrf2) was knocked down by siRNA transfection. The effect of curcumin on intracellular reactive oxygen species (ROS) was measured by a ROS-specific dye. Annexin V-FITC/propidium iodide (PI) double labeling was applied to determine apoptosis. The expressions of apoptosis-associated proteins and Nrf2-Kelch-like ECHassociated protein 1 (Keap 1) pathway activation were assessed by western blotting, while target gene transcription was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR).
Results: Curcumin reduced the levels of intracellular ROS and apoptosis induced by H2O2, upregulated B-cell lymphoma-2 (Bcl-2), downregulated Bcl2-associated X (Bax), and activated caspase-3 and nine other proteins (p < 0.05). Curcumin reduced the expressions of Nrf2, HO-1, and NQO1, and increased Keap1 in H2O2-induced TMCs (p < 0.05). Moreover, Nrf2 knockdown partly reversed the effect of curcumin on ROS and apoptosis in TMCs induced by H2O2 (p < 0.05).
Conclusion: Curcumin inhibited oxidative stress and apoptosis by Nrf2-Keap1 activation in TMCs. Curcumin is therefore a potential therapeutic agent for the management of glaucoma.
Keywords: Curcumin, Oxidative stress, Apoptosis, Glaucoma, Nrf2-Keap1
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.